PMGC Holdings Inc. financial data

Symbol
ELAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
120 Newport Center Drive, Ste 250, Newport Beach, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Elevai Labs Inc. (to 11/27/2024), Reactive Medical Labs Inc. (to 10/14/2021)
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 274 %
Quick Ratio 51.7 %
Debt-to-equity 45.1 %
Return On Equity -123 % +66.9%
Return On Assets -84.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 707K shares -95.9%
Common Stock, Shares, Outstanding 439K shares
Entity Public Float 7.61M USD +54.8%
Common Stock, Value, Issued 44 USD
Weighted Average Number of Shares Outstanding, Basic 79.6K shares

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.45M USD -4.9%
Cost of Revenue 134K USD -29.1%
Research and Development Expense 105K USD +1312%
Selling and Marketing Expense 1.56M USD +533%
General and Administrative Expense 1.09M USD +214%
Operating Income (Loss) -920K USD -17.1%
Net Income (Loss) Attributable to Parent -6.25M USD -45.2%
Earnings Per Share, Basic -0.31 USD/shares +12.8%
Earnings Per Share, Diluted -0.31 USD/shares +12.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.98M USD +19.8%
Inventory, Net 986K USD
Assets, Current 6.05M USD +23%
Property, Plant and Equipment, Net 1.09K USD -37.6%
Operating Lease, Right-of-Use Asset 101K USD
Intangible Assets, Net (Excluding Goodwill) 2.8M USD
Assets 8.99M USD +73.3%
Accounts Payable, Current 1.08M USD
Accrued Liabilities, Current 138K USD
Liabilities, Current 1.8M USD +38.7%
Operating Lease, Liability, Noncurrent 26.6K USD
Liabilities 2.33M USD +71.2%
Common Stocks, Including Additional Paid in Capital 7.04M USD +2718%
Accumulated Other Comprehensive Income (Loss), Net of Tax -337 USD -267%
Retained Earnings (Accumulated Deficit) -13.3M USD -88.9%
Stockholders' Equity Attributable to Parent 6.66M USD +74%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.83M USD
Liabilities and Equity 8.99M USD +73.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.32M USD -162%
Net Cash Provided by (Used in) Investing Activities -59.2K USD -429%
Common Stock, Shares Authorized 286M shares 0%
Common Stock, Shares, Issued 439K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.38M USD -2085%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.98M USD +19.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.54K USD +72.3%
Operating Lease, Liability 103K USD
Depreciation 21.2K USD +628%
Payments to Acquire Property, Plant, and Equipment 9.16K USD -18.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -6.25M USD -45.2%
Lessee, Operating Lease, Liability, to be Paid 108K USD
Property, Plant and Equipment, Gross 82K USD
Operating Lease, Liability, Current 103K USD -26.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 67.4K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 67.4K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.51K USD
Deferred Tax Assets, Operating Loss Carryforwards 3.32M USD +94.3%
Preferred Stock, Shares Authorized 75M shares 0%
Additional Paid in Capital 10.8M USD +182%
Share-based Payment Arrangement, Expense 55.3K USD -26.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%